Evidence map›Paper›PMID 32155148›Full record

ArticlePLoS neglected tropical diseases2020

Surveillance of Salmonella enterica serovar  Typhi in Colombia, 2012-2015.

Paula Diaz-Guevara, Lucy Angeline Montaño, Carolina Duarte, Gabriela Zabaleta, Mailis Maes, Julio Cesar Martinez Angarita, Duy Pham Thanh, William León-Quevedo, Carlos Castañeda-Orjuela, Claudia Jimena Alvarez Alvarez and 5 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Pathogen genomic surveillance of typhoidalTropical medicine and health · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Paula Diaz-GuevaraGrupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.ORCID 0000-0002-8252-5622
Lucy Angeline MontañoGrupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.
Carolina DuarteGrupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.
Gabriela ZabaletaGrupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.
Mailis MaesCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), The University of Cambridge, Cambridge, United Kingdom.
Julio Cesar Martinez AngaritaVigilancia y Análisis de Riesgo en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Duy Pham ThanhOxford University Clinical Research Unit, The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
William León-QuevedoObservatorio Nacional de Salud, Instituto Nacional de Salud, Bogotá, Colombia.
Carlos Castañeda-OrjuelaObservatorio Nacional de Salud, Instituto Nacional de Salud, Bogotá, Colombia.
Claudia Jimena Alvarez AlvarezVigilancia y Análisis de Riesgo en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Jaime GuerreroVigilancia y Análisis de Riesgo en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Miriam MoroniRed Pulsenet Latino América y el Caribe, Subregional, Instituto Carlos Malbran, Buenos Aires, Argentina.
Josefina CamposRed Pulsenet Latino América y el Caribe, Subregional, Instituto Carlos Malbran, Buenos Aires, Argentina.
Enrique PérezHealth Emergencies Department, Pan American Health Organization/World Health Organization, PAHO/WHO, Washington DC, United States of America.
Stephen BakerCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), The University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-1308-5755

Funding

World Health Organization 001
6 · The paper itself

Abstract

Salmonella Typhi (S. Typhi) is the causative agent of typhoid fever; a systemic disease affecting ~20 million people per year globally. There are little data regarding the contemporary epidemiology of typhoid in Latin America. Consequently, we aimed to describe some recent epidemiological aspects of typhoid in Colombia using cases reported to the National Public Health Surveillance System (Sivigila) between 2012 and 2015. Over the four-year reporting period there were 836 culture confirmed cases of typhoid in Colombia, with the majority (676/836; 80.1%) of reported cases originated from only seven departments. We further characterized 402 S. Typhi isolates with available corresponding data recovered from various departments of Colombia through antimicrobial susceptibility testing and molecular subtyping. The majority (235/402; 58.5%) of these typhoid cases occurred in males and were most commonly reported in those aged between 10 and 29 years (218/402; 54.2%); there were three (0.74%) reported fatalities. The overwhelming preponderance (339/402; 84.3%) of S. Typhi were susceptible to all tested antimicrobials. The most common antimicrobial to which the organisms exhibited non-susceptibility was ampicillin (30/402;7.5%), followed by nalidixic acid (23/402, 5.7%). Molecular subtyping identified substantial genetic diversity, which was well distributed across the country. Despite the diffuse pattern of S. Typhi genotypes, we identified various geographical hotspots of disease associated with local dominant genotypes. Notably, we found limited overlap of Colombian genotypes with organisms reported in other Latin American countries. Our work highlights a substantial burden of typhoid in Colombia, characterized by sustained transmission in some regions and limited epidemics in other departments. The disease is widely distributed across the country and associated with multiple antimicrobial susceptible genotypes that appear to be restricted to Colombia. This study provides a current perspective for typhoid in Latin America and highlights the importance of pathogen-specific surveillance to add insight into the limited epidemiology of typhoid in this region.

Indexed as

AdolescentAdultAgedAged, 80 and overAge DistributionChildChild, PreschoolColombiaDrug Resistance, BacterialEpidemiological MonitoringFemaleGenetic VariationGenotypeHumansInfantMale

Identifiers

PMID32155148
PMCPMC7083327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.